Notre Dame Stories: Developing a COVID-19 Vaccine

Author: Andy Fuller

COVID-19 Vaccine

As most of the country awaits their turn in line to receive a coronavirus vaccine, some have questions about its safety, how it was developed, and what it means for life…after the vaccination.

Today we talk with Dr. Mark Mulligan '80, an infectious disease expert and head of NYU’s Langone Vaccine Center. Dr. Mulligan has worked on vaccine trials for decades, including most recently, the vaccine for COVID-19.

Notre Dame Stories highlights the work and knowledge of the University's faculty and students. This podcast features interviews with Notre Dame faculty members who can lend insight into some of the major national and international stories of the day, as well as pieces that show the breadth of the life and research at the University.

Listen to more episodes here.